Predict your next investment

Tempus company logo
Corporation
HEALTHCARE | Biotechnology
tempus.com

See what CB Insights has to offer

Founded Year

2015

Stage

Series G - II | Alive

Total Raised

$1.07B

Valuation

$0000 

Last Raised

$200M | 10 mos ago

About Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Tempus Headquarter Location

600 West Chicago Avenue Suite 510

Chicago, Illinois, 60654,

United States

833-514-4187

Latest Tempus News

US dollar rises, lifted by higher Treasury yields

Sep 27, 2021

US dollar rises, lifted by higher Treasury yields US dollar rises, lifted by higher Treasury yields FILE PHOTO: A U.S. hundred dollar bill and Japanese 10,000 yen notes are seen in this photo illustration in Tokyo, February 28, 2013. REUTERS/Shohei Miyano/File Photo FILE PHOTO: A U.S. dollar note (bottom) is pictured alongside an Australian 10 dollar (L) and 20 dollar bill in this picture illustration taken in Washington, October 14, 2010. REUTERS/Jason Reed/File Photo 27 Sep 2021 10:39AM (Updated: 27 Sep 2021 10:14PM) NEW YORK/LONDON :The U.S. dollar gained for a second straight session on Monday, bolstered by the rise in Treasury yields ahead of a slew of Federal Reserve speakers this week who could reinforce expectations of the start of asset purchase tapering before the end of the year. U.S. benchmark 10-year Treasury yields hit a three-month high of US$1.516per cent. [US/] Fed speakers will be in focus this week, led by Chair Jerome Powell, who will join Treasury Secretary Janet Yellen in speaking before Congress on Tuesday. The dollar index, which measures the U.S. currency against six major rivals, rose 0.2per cent to 93.442. The greeback also extended gains after data showed new orders and shipments of key U.S.-made capital goods increased solidly in August, rising 0.5per cent in August amid strong demand for computers and electronic products. But the market has been more focused on the U.S. Treasury market. U.S. yields climbed to their highest since late June in anticipation of tighter U.S. monetary policy after the Fed announced last week that it may start tapering stimulus as soon as November and flagged interest rate increases may follow sooner than expected. "Yields are higher because there is a stronger belief in markets that the Fed will choreograph a tapering move before the year ends," said Juan Perez, FX strategist and trader at Tempus Inc in Washington. "Nevertheless, there are too many items to really have a clear picture of anything at the moment. One thing is clear is the dollar was a winner from the slowdown that the Delta variant caused, which was both physical and psychological and diminished the excitement that was built during the second quarter," he added. The euro fell 0.2per cent against the dollar to US$1.1692. Moves in the currency pair largely ignored developments in German elections at the weekend, with the Social Democrats projected to narrowly defeat the CDU/CSU conservative bloc. The European Central Bank, meanwhile, hosts an annual forum on Tuesday and Wednesday, with not only ECB President Christine Lagarde speaking to open day one, but also joining a panel discussion on day two with Powell, Bank of Japan Governor Haruhiko Kuroda and Bank of England Governor Andrew Bailey. The dollar rose 0.2per cent versus the yen to 110.925, after earlier rising to a near three-month high. It gained 0.4per cent versus the Swiss franc to 0.9275 francs. The risk-sensitive Australian dollar climbed as fears of widespread market contagion from indebted China Evergrande Group receded. Rising commodity prices also helped the Aussie and Norway's crown, while the yen was pressured as higher U.S. yields attracted Japanese investor money. Concerns that Evergrande, China's second-largest developer, could default on its US$305 billion of debt have overshadowed trade in recent weeks, but some of those contagion fears are receding. The People's Bank of China injected a net 100 billion yuan (US$15.5 billion) into the financial system on Monday, adding to the net 320 billion yuan last week, the most since January. ======================================================== Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid Previous Change

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tempus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tempus is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

U

Unicorns- Billion Dollar Startups

863 items

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

A

AI 100 2018

99 items

A

Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.

C

Clinical Trials Tech

311 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

Tempus Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Tempus Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.